Naoto Okada

1.4k citations
63 papers · 863 indexed · h-index 17
Topics
Antibiotics Pharmacokinetics and Efficacy (6 papers)Lung Cancer Treatments and Mutations (6 papers)Multiple Myeloma Research and Treatments (5 papers)
Journals
SHILAP Revista de lepidopterologíaClinical Infectious DiseasesScientific Reports
Partner nations
JapanUnited Kingdom

In The Last Decade

Naoto Okada

54 papers receiving 841 citations

Peers

Naoto Okada
Comparison fields: 5 of 103
  • Oncology 433
  • Pulmonary and Respiratory Medicine 242
  • Surgery 140
  • Molecular Biology 119
  • Physiology 88
Replace Guangjin Yuan with:
Guangjin Yuan China
Caiming Xu China
David Cucchiari Spain
Alexander Zipprich Germany
Amelia Maria Găman Romania
Toshihisa Takeuchi Japan
Xiaoli Liu China
Sisi Chen China
Yiwen Liu China
Yuan Yin China
Naoto Okada relative to Guangjin Yuan China Guangjin Yuan's profile →
Citations per field
00.5×6.8×
Guangjin Yuan · 1×
Citations per year

Countries citing papers authored by Naoto Okada

Since Specialization
Citations

This map shows the geographic impact of Naoto Okada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naoto Okada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naoto Okada more than expected).

Fields of papers citing papers by Naoto Okada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naoto Okada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naoto Okada. The network helps show where Naoto Okada may publish in the future.

Co-authorship network of co-authors of Naoto Okada

This figure shows the co-authorship network connecting the top 25 collaborators of Naoto Okada. A scholar is included among the top collaborators of Naoto Okada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naoto Okada. Naoto Okada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 0
4 0
5 0
6 2
7 2
8 0
9 7
10 1
11 21
12 1
13 5
14 14
15 85
16 8
17 15
18 18
19 47
20 10

About Naoto Okada

Naoto Okada is a scholar working on Applied Microbiology and Biotechnology, Oncology and Hematology, having authored 63 papers that have together received 863 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (6 papers), Lung Cancer Treatments and Mutations (6 papers) and Multiple Myeloma Research and Treatments (5 papers). The work is most often cited by research in Oncology (433 citations), Applied Microbiology and Biotechnology (19 citations) and Pulmonary and Respiratory Medicine (242 citations). Naoto Okada has collaborated with scholars based in Japan and United Kingdom. Frequent co-authors include Keisuke Ishizawa, Yoshito Zamami, Kazuyoshi Kawazoe, Mitsuhiro Goda, Masayuki Chuma, Takahiro Niimura, Yuki Izawa‐Ishizawa, Keijo Fukushima, Yasuo Shinohara and Toshihiro Koyama. Their work appears in journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026